SEC Comment Letter for Q BioMed Inc. (QBIO) (CIK 0001596062) — May 5, 2020
Q BioMed Inc. (QBIO) (CIK 0001596062)
Date: May 5, 2020 · CIK: 0001596062 · Accession: 0000000000-20-003932
AI Filing Summary & Sentiment
File numbers found in text: 333-237872
Letter
United States securities and exchange commission logo May 5, 2020 Denis Corin Chief Executive Officer Q BioMed Inc. c/o Ortoli Rosenstadt LLP 366 Madison Avenue, 3rd Floor New York, New York 10017 Re:Q BioMed Inc. Registration Statement on Form S-1 Filed April 28, 2020 File No. 333-237872 Dear Mr. Corin: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Courtney Lindsay at (202) 551-7237 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: William Rosenstadt
Show Raw Text
United States securities and exchange commission logo
May 5, 2020
Denis Corin
Chief Executive Officer
Q BioMed Inc.
c/o Ortoli Rosenstadt LLP
366 Madison Avenue, 3rd Floor
New York, New York 10017
Re:Q BioMed Inc.
Registration Statement on Form S-1
Filed April 28, 2020
File No. 333-237872
Dear Mr. Corin:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Courtney Lindsay at (202) 551-7237 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: William Rosenstadt